Capillary electrophoresis system BioPhase 8800

for laboratory

Multiply your results. Multiply your success. Accelerate the development of your biotherapeutics. Innovated from the ground up, the BioPhase 8800 system helps biopharmaceutical labs take charge of their development pipelines. Scientists can now assess molecular liabilities more quickly, allowing rapid developability assessments to streamline the selection of candidates to be progressed into an effective therapy. Features Run more s amples, and more molecules, on a single system through not 1, but 8 capillaries in parallel. Existing approaches to detect and characterize changes during development of monoclonal antibodies (mAbs), next-generation therapeutics and gene therapies are challenged to deliver the detailed information you need in the time you need it. The BioPhase 8800 system facilitates parallel processing of 8 samples simultaneously, while retaining the capability to deliver sensitive capillary electrophoresis sodium dodecyl sulfate (CE-SDS), ribonucleic acid (RNA), capillary isoelectric focusing (cIEF) and glycan characterization analysis, enabling uncompromised accuracy for large sample sets and faster time to answers. Overcome QTOF MS/MS duty cycle deficiencies Expand Take on multiple molecules and multiple applications in less time—all on a single platform. Tunable fragmentation of all molecule types Accelerate Shorten time to market with high-throughput, 8-capillary analytics. MS/MS scan rates of up to 133Hz Simplify With user-friendly software and pre-packaged reagents, running applications on the the BioPhase 8800 system is quick and easy.